A Twelve-Month, Phase II, Randomized, Open-Label, Multi-

Project: Research project

Project Details

Description

A Twelve-Month, Phase II, Randomized, Open-Label, Multi-Center, Dose-Ranging Study of Weekly ALTU-238 (Somatropin) as Compared with Daily Nutropin AQ (Somatropin) in Prepubertal Children with Growth Hormone Deficiency
StatusFinished
Effective start/end date11/4/089/11/09

Funding

  • Altus Pharmaceuticals Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.